First day Affordable Care Act (ACA) enrollment surpassed numbers from last year; CVS will offer next-day and same-day prescription delivery in 2018; and voter confusion surrounds Ohio's drug-pricing ballot measure.
In the first few days of open enrollment for the Affordable Care Act (ACA), numbers of people enrolling in coverage have surpassed the previous year. On the first day, more than 200,000 Americans chose a plan, which is more than double the number who signed up on day 1 in 2016, reported The Washington Post. Despite the White House reducing funding for promoting the ACA, traffic to HealthCare.gov was up 33% over last year. State exchanges are reporting similar increases. For example, Colorado reported more than 4000 people logged into the exchange, far surpassing the expected 2700.
With Amazon’s potential entry hanging over the pharmacy industry, CVS has announced a new strategy to offer next-day delivery of prescription drugs in 2018. In some big cities, CVS will offer same-day service, according to The New York Times. The announcement also follows falling retail sales, including prescription sales. At this time, the delivery partner for CVS has not yet been announced.
Ads around Ohio’s Drug Price Relief Act has muddied the waters and caused confusion for voters, who will need to weigh in on the single ballot-box question next week. According to Kaiser Health News, the act is supposed to combat rising drug costs, and the issue has gotten a lot of attention. Opponents and supporters have spent $58 million and $14 million, respectively. A similar measure was rejected in California last year.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen